Equillium, Inc. (EQ) vs Rallybio Corporation (RLYB)
- Equillium, Inc. EQ 1.41 −2.08%
- Rallybio Corporation RLYB 17.02 +0.18%
Equillium, Inc. and Rallybio Corporation are both Biotechnology companies. Equillium, Inc. and Rallybio Corporation are of similar size ($91.3M and $90.2M). Equillium, Inc. has negative trailing earnings, so its P/E is not meaningful; Rallybio Corporation trades at 2.1×. Equillium, Inc. grew revenue faster over the last twelve months: 13.9% against 1.18%. Across the 12 metrics below, Rallybio Corporation leads on 7 and Equillium, Inc. on 5.
Valuation
Profitability
| Metric | EQ | RLYB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (58.98%) | 64.86% | (56.66%) |
| Return on assets | (50.68%) | 61.12% | (49.22%) |
| Return on invested capital | 0.00% | (1,052.03%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack